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ABSTRACT
Background Globally, 2.5 million neonates died
in 2018, accounting for 46% of under-5 deaths.
Multiparameter continuous physiological monitoring
(MCPM) of neonates allows for early detection and
treatment of life-threatening health problems. However,
neonatal monitoring technology is largely unavailable in
low-resource settings.
Methods In four evaluation rounds, we prospectively
compared the accuracy of the EarlySense under-mattress
device to the Masimo Rad-97 pulse CO-oximeter with
capnography reference device for heart rate (HR) and
respiratory rate (RR) measurements in neonates in
Kenya. EarlySense algorithm optimisations were made
between evaluation rounds. In each evaluation round, we
compared 200 randomly selected epochs of data using
Bland-Altman plots and generated Clarke error grids
with zones of 20% to aid in clinical interpretation.
Results Between 9 July 2019 and 8 January 2020, we
collected 280 hours of MCPM data from 76 enrolled
neonates. At the final evaluation round, the EarlySense
MCPM device demonstrated a bias of −0.8 beats/
minute for HR and 1.6 breaths/minute for RR, and
normalised spread between the 95% upper and lower
limits of agreement of 6.2% for HR and 27.3% for RR.
Agreement between the two MCPM devices met the a
priori–defined threshold of 30%. The Clarke error grids
showed that all observations for HR and 197/200 for RR
were within a 20% difference.
Conclusion Our research indicates that there is
acceptable agreement between the EarlySense and
Masimo MCPM devices in the context of large within-
subject variability; however, further studies establishing
cost-effectiveness and clinical effectiveness are needed
before large-scale implementation of the EarlySense
MCPM device in neonates.
Trial registration number NCT03920761.

What is already known on this topic?
►► Sustainable Development Goal 3’s focus on

treatment and prevention of acute illness
calls for development and optimisation of
innovations for neonatal care in low-resource
settings.
►► Continuous monitoring of neonatal heart and
respiratory rates is rarely performed in low-
resource settings due to poor availability of
monitoring technologies and high acquisition
costs.
►► Almost all studies of automated monitoring
technologies have been conducted in high-
resource settings, making it difficult to assess
these technologies for use in low-resource
settings.

What this study adds?
►► This is a novel evaluation of the accuracy

of a contactless multiparameter continuous
monitoring device compared with a reference
standard in neonates in a low-resource setting.
►► We describe a method for and some of the
challenges in performing monitoring device
accuracy studies in neonates.
►► Our study indicates acceptable agreement
between the EarlySense device and the Masimo
Rad-97 reference device for measurement of
heart and respiratory rates.

Technologies that can detect vulnerability and
prompt interventions have great potential to
improve neonatal survival. Multiparameter continuous physiological monitoring (MCPM) devices
could be key in identifying high-
risk neonates.
INTRODUCTION
Studies have demonstrated that monitoring of vital
High neonatal mortality rates persist in Sub- sign trends can predict clinical deterioration and
Saharan Africa, with 27 deaths/1000 live births, allow for timely intervention and improvement in
a rate 10 times higher than rates in high-resource health outcomes.4–8 However, neonatal MCPM
settings.1 Interventions are urgently needed, partic- devices are not available in most low-
resource
ularly in low-resource African settings, if Sustain- settings due to barriers such as the high cost of
able Development Goal Target 3.2 of reducing equipment and a lack of health personnel with
neonatal mortality to 12 deaths/1000 live births is appropriate training.9 10
to be achieved by 2030.2
A better understanding of if and how MCPM
Major causes of neonatal mortality include devices can be adapted and optimised for use in
complications of preterm birth, asphyxia, and infec- neonates in low-
resource settings is critical. Our
tious diseases which are preventable and treatable.3 study’s primary outcomes were agreement of heart
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rate (HR) and respiratory rate (RR) measurements comparing
the EarlySense (EarlySense, Israel) investigational device to the
Masimo Rad-97 pulse CO-oximeter with capnography (Masimo
Corporation, USA) reference device. We hypothesised that the
EarlySense device would agree within a priori–defined thresholds for HR and RR measurements when compared with the
reference device and show minimal bias.

Global child health

METHODS
Study design and procedures

We conducted an iterative prospective study at Aga Khan University, Nairobi (AKU-N), a tertiary healthcare facility in Kenya, to
assess agreement of HR and RR measurements from the EarlySense investigational device with those from the Masimo Rad-97
reference device.10 The Masimo Rad-
97 device was selected
based on its capability for high-resolution data collection and
neonatal capnometry and pulse oximetry. EarlySense’s contactless wireless piezoelectric sensor can be placed under a patient’s
mattress to detect ballistic vibrations from respiratory chest wall
movement and cardioballistic movements from ejection of blood
(online supplemental appendix A).
97 reference device verification, we
During Masimo Rad-
tested functionality and estimated within-neonate and between-
neonate variability to pre-
specify thresholds for agreement
comparisons.11 We completed an initial round of open-label data
collection from both devices in which complete reference device
data were shared with EarlySense prior to analysis. Three rounds
of closed-label analysis followed, in which the first 15–30 min of
reference device data from each neonate were provided to EarlySense to confirm time synchronicity across data sources (online
supplemental appendices B, C). All reference device data were
provided to EarlySense on completion of each subsequent round
of data analysis to optimise HR and RR detection algorithms.
Caregivers of neonates delivered at AKU-N during the study
period were approached for recruitment into the study and
Table 1

trained study clinicians obtained informed consent prior to
determining eligibility for enrolment (table 1). Enrolled neonates
were simultaneously monitored by both devices (figure 1; online
supplemental video 1).

Data processing and selection

To ensure accurate, reliable and consistent data collection, we
conducted the study in accordance with the Guideline for Good
Clinical Practice/International Standards Organization (ISO)
14 155.
We randomly selected epochs of HR and RR with sufficient signal quality for each neonate recording (table 1). The
first 5 min and last minute of recorded data, and first minute
prior to and 5 min following any device or sensor disconnection
were excluded to remove potentially poor-quality data typically
present during sensor placement and removal. For the open-
label round, we selected 20 epochs from ten different neonates.
For each closed-label round, we selected ten epochs from 20
different neonates. No overlapping epochs were selected, and
missing data were excluded from analyses. Median HR and RR
values were calculated for the selected epochs (table 1). Manual
RR counting was performed for each epoch using capnograms
(online supplemental appendix D). Any RR epochs meeting
exclusion criteria were replaced with another randomly selected
epoch (table 1). See online supplemental appendix E for more
details.

Statistical analysis

To quantify the agreement between the EarlySense and reference devices, the normalised bias (95% CI) and the normalised
spread between the 95% limits of agreement (LOA) were calculated by dividing the bias and spread between the 95% LOA by
the overall reference HR or RR mean value.12 Based on a verification phase, the acceptable a priori-defined normalised spread

Eligibility criteria and study definitions

Eligibility criteria
Inclusion criteria

►► Corrected age of <28 days
►► Caregivers were willing and able to provide informed consent and were available for follow-up for the duration of the study

Exclusion criteria

►►
►►
►►
►►
►►
►►

Receiving continuous positive airway pressure or mechanical ventilation
Skin abnormalities in the nasopharynx and/or oropharynx
Contraindication to skin sensor application
Known arrhythmia
Congenital abnormality requiring major surgical intervention
Any medical or psychosocial condition or circumstance that would interfere with study conduct or for which study participation could put the neonate’s
health at risk

Study definitions

2

Epoch

A 60 s period of time

Breath

One cycle of neonate-initiated inhalation and exhalation

Breath start

End of a waveform trough (low point) where the carbon dioxide level starts to ascend

Respiratory rate (RR) manual
counting protocol

A breath was counted if the waveform peak reached either 15 mmHg or the average peak of the epoch, AND the waveform trough dipped below the average
trough of the epoch plus 10 mmHg
►► Each plot was counted by two independent readers and averaged
►► If the difference in the counts was >5, a third independent reader counted the plot
►► If the third count was within 5 breaths of either previous count, the average of the two closest counts was used

RR epoch exclusion criteria

RR epoch excluded if (i) the difference between the epoch count and median RR was >10, (ii) either value was <15, (iii) the capnogram contained a digital
artefact or (iv) if there was lack of inter-reader manual count agreement

RR median calculation

For each breath in an epoch, an instantaneous RR could be calculated by the breath duration, and the median of all these instantaneous RR values in an epoch
was then calculated

Heart rate (HR) median
calculation

Heart beats were identified by the timing of the Masimo Rad-97 reference device plethysmograph quality index (PO-SQI) which occur at the peak of each
heart beat. For each heart beat in an epoch, an instantaneous HR could be calculated by the time between the previous heart beat peak and current heart
beat peak, and the median of all these instantaneous HR values in an epoch was then calculated

Adequate signal quality

EarlySense device: A signal quality score ≥0.7 for at least 50% of the epoch
Masimo Rad-97 reference device: plethysmograph quality index (PO-SQI) threshold >150 for 100% of the epoch for HR, and capnography quality score (CO2-
SQI) threshold ≥2 for at least 90% of the epoch for RR
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Figure 1 (A) Overview of the set-up showing the Masimo Rad-
97 device with touchscreen interface (1), pulse oximeter probe
(2), Nomoline for capnography (3), EarlySense processing unit (4),
EarlySense under-mattress sensor (5). (B) Close-up of the EarlySense
sensor under a mattress. The EarlySense sensor is connected to the
processing unit that processes, stores data and sends results wirelessly
to the remote display unit where the data are presented.
between the 95% upper and lower LOAs of 30% was selected
for both RR and HR.11 We calculated the root-
mean-
square
deviation (RMSD) for each comparison. Clarke error grids were
constructed with zones of 20% discrepancy to improve clinical
interpretability of results.

RESULTS

We enrolled 94 neonates from 9 July 2019 to 8 January 2020,
76 of which were included for analysis (online supplemental
appendix F). Three neonates withdrew prior to the minimum
data collection time, and 15 neonates were excluded due to
issues with data identification (incorrect date/times recorded) or
time synchronisation (10), insufficient (less than 1 hour) length
of recording (4) or poor data quality (1). There were six recordings where only one of the vital signs was usable for analysis

due to poor data quality. There were no adverse events due to
monitoring.
Equal numbers of female and male neonates from the neonatal
high dependency unit (64.5%), postnatal and maternal wards
(34.2%), and neonatal intensive care unit (1.3%) were included
for analysis. Median gestational age was 38 (range 28–42) weeks
delivery (35.5%),
and primary diagnoses were healthy post-
prematurity (27.6%), jaundice (17.1%), hypoglycaemic (6.6%),
respiratory distress syndrome (5.3%), low birth weight (3.9%)
and other (3.9%). We collected 280 hours of data (online
supplemental appendix G), with a median recording length of
4 hours (range 73–423 min). See online supplemental appendix
H for additional results.
HR analysis identified a small negative average bias (range
−1.58 to −0.55 beats/minute) with normalised spread of LOA
meeting the a priori–defined threshold for all rounds (table 2;
figure 2). A marked decrease in normalised spread between 95%
LOA between closed-label rounds 2 and 3 (20.1 vs 6.2%) was
observed. All EarlySense HR measurements were within 20% of
the reference device values (figure 3).
RR analyses showed a small positive average bias in the EarlySense device (range 0.17–1.62 breaths/minute) when compared
with reference device RR manual counts and a small negative
average bias (range −1.65 to −0.63 breaths/minute) when
compared with RR median values (table 2; figure 4). Normalised
spread between 95% LOA decreased between the open-label
and first two closed-label rounds, with results from closed-label
rounds 2 and 3 meeting the a priori–defined threshold for both
RR manual counts and median values. A marked decrease in
normalised spread between 95% LOA from closed-label rounds
1 and 2 (37.6 vs 24.8% for RR manual counts; 35.9 vs 19.2%
for RR medians) was observed. Absolute and normalised spreads
of 95% LOA for RR median values were consistently smaller
than RR manual counts when comparing the EarlySense and
reference devices. Of the data pairs from closed-label round 3,
only three (1.5%) EarlySense RR values were outside 20% of the
reference device values (figure 3).

Table 2 Results from Bland-Altman analysis for EarlySense investigational device versus Masimo Rad-97 reference device heart rate (HR) and
respiratory rate (RR) measurements
Open label

Closed-label round 1

Closed-label round 2

Closed-label round 3

EarlySense HR compared with Masimo Rad-97 HR
Mean Masimo Rad-97 HR

132.3

128.2

139.1

130.2

Normalised bias (95% CI)

−0.5%
(−1.2% to 0.2%)

−1.2%
(−1.8% to −0.7%)

−0.4%
(−1.1% to 0.3%)

−0.6%
(−0.9% to −0.4%)

Normalised spread between 95% LOA (upper and lower
95% LOA)

19.7%
(−10.4% to 9.4%)

15.3%
(−8.9% to 6.4%)

20.1%
(−10.5% to 9.7%)

6.2%
(−3.7% to 2.5%)

Normalised RMSD

5.0%

4.1%

5.1%

1.7%

EarlySense RR compared with Masimo Rad-97 RR manual count
Mean Masimo Rad-97 RR

48.0

51.7

54.2

48.5

Normalised bias (95% CI)

3.0%
(1.4% to 4.6%)

0.3%
(−1.0% to 1.7%)

2.5%
(1.6% to 3.4%)

3.3%
(2.4% to 4.3%)

Normalised spread between 95% LOA (upper and lower
95% LOA)

45.3%
(−19.7% to 25.6%)

37.6%
(−18.4% to 19.1%)

24.8%
(−9.9% to 14.9%)

27.3%
(−10.4% to 17.0%)

Normalised RMSD

11.9%

9.6%

6.8%

7.7%

EarlySense RR compared with Masimo Rad-97 RR median
Mean Masimo Rad-97 RR

50.3

53.5

56.4

50.7

Normalised bias (95% CI)

−1.9%
(−3.4% to −0.4%)

−3.1%
(−4.4% to −1.8%)

−1.5%
(−2.2% to −0.8%)

−1.2%
(−1.9% to − 0.5%)

Normalised spread between 95% LOA (upper and lower
95% LOA)

41.6%
(−22.7% to 18.9%)

35.9%
(−21.1% to 14.9%)

19.2%
(−11.1% to 8.2%)

19.8%
(−11.1% to 8.7%)

Normalised RMSD

10.8%

9.7%

5.1%

5.2%

LOA, limits of agreement; RMSD, root-mean-square deviation.
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Figure 2 Bland-Altman plots for heart rate (HR). (A) Open-label round. (B) Closed-label round one. (C) Closed-label round two. (D) Closed-label
round three. Colours indicate which participant neonate is associated with the measurement pair.

DISCUSSION

We found acceptable agreement between the EarlySense and
reference devices for measurement of HR and RR in neonates
by the final round of analysis, as evidenced by normalised spread
between 95% LOA values below the a priori–defined threshold
of 30%. The EarlySense algorithms were optimised between
closed-label rounds 1 and 2 for RR, and between closed-label
rounds 2 and 3 for HR. Upon optimisation, a marked narrowing
of normalised spread between 95% LOA and reduction in bias
was observed. Clarke error grids showed that all observations
for HR and 197/200 for RR fell in region A (20% difference)
(figure 3).
Selection of a reference standard is key when evaluating accuracy of a MCPM device. While ECG is the accepted reference
standard for HR measurement, plethysmogram-derived HR, as
used by the Masimo Rad-97 device, has been shown to be accurate even for comparisons of HR variability that require precise
timing in identification of the heartbeat.13 The EarlySense device
uses ballistocardiography (BCG). In comparison with ECG,
heartbeats are less pronounced and more difficult to detect in
BCG signals due to a lower signal-to-noise ratio14; yet, BCG
signals have been shown to accurately estimate HR in adults.15
We selected capnography as the RR reference method.16
Agreement between RR measurements was impacted by within-
neonate RR variability, which is particularly pronounced in
neonates due to immature control of respiration, and normal and
abnormal physiological responses such as periodic breathing and
periods of apnoea.17 There are currently no recommended ISO
standards for RR accuracy, though United Nations International
4

Child’s Fund has suggested a maximum variability of ±2 breaths/
minute in their acute respiratory infection diagnostic aid target
product profile.18 This threshold may be unreasonably conservative when considering a neonate breathing at 60 breaths/minute,
neonate variation of 2 breaths/minute would
where a within-
equate to a 3.3% variation. In setting the 30% threshold for
the spread between 95% LOA, we considered the large within-
neonate RR variability present in the verification phase data
and avoided setting the target agreement threshold to be more
restrictive than the within-
neonate variation.11 We chose to
normalise the spread between 95% LOA and used a percentage
error threshold to allow for comparison of performance over
a wide range of RR values. Use of a ±30% error threshold for
LOA to determine whether to accept a new method in cardiac
output method comparison studies was proposed in 1999 and
has since been used extensively in the field.19
We compared EarlySense RR measurements to reference device
RR manual counts and medians. Since clinical measurement of
RR is typically determined by counting the number of breaths
over a 1 min period, comparison of EarlySense RR values to RR
manual counts was used as the primary comparison. However,
manual count methods have several limitations. Capnograms
can contain several different breathing patterns, such as periodic breathing and small-amplitude breaths, and it is unclear
which breathing patterns should be included in a manual count
and which should cause a minute to be excluded. In addition,
rounding is a significant consequence of counting breaths. The
rounding error may be as much as 6.7% if considering a RR of
15 breaths/minute and a rounding error of 1 breath/minute. We
Wang D, et al. Arch Dis Child 2021;0:1–7. doi:10.1136/archdischild-2021-322344
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Figure 3 Clarke error grids for closed-label round three
measurements. (A) Comparison of heart rate (HR) measurements. (B)
Comparison of EarlySense respiratory rate (RR) to Masimo Rad-97 RR
manual count. Each dot represents a data pair, with the colour intensity
proportional to density of data pairs. Region A (in green) contains data
pairs that are within 20% of the Masimo Rad-97 device value. Region
B (in yellow) contains data pairs not within 20% that would not lead to
unnecessary treatment. Regions C, D and E are in red. C includes data
pairs leading to unnecessary treatment. D includes data pairs with a
failure in detecting low or high HR/RR events and E includes data pairs
where low and high HR/RR events are confused.

used a comparison between EarlySense RR and reference device
RR median values since median values are more likely to reflect
the underlying control of breathing. Medians are more robust
than means, especially in the presence of extreme outliers, and
are often used in automated device signal processing methods.
This may explain the greater agreement when comparing
the EarlySense RR to the reference device medians versus RR
manual counts.
We reported RMSD values, as the accuracy of HR and RR has
typically been reported as a percentage error rate (such as ±2%)
compared with a reference standard.20 While RMSD is provided
as a standardised metric when performing comparisons, RMSD
does not consider the uncertainty in the reference method. In this
evaluation, the normalised RMSD was 1.7% for HR, and 7.7%
and 5.2% for RR manual counts and median values, respectively,
Wang D, et al. Arch Dis Child 2021;0:1–7. doi:10.1136/archdischild-2021-322344

in the final round (table 2). This was approximately 25% of the
value of normalised spread between 95% LOA.
The study results indicate that the EarlySense MCPM device
performs well when used to measure HR and RR as compared
with the more invasive Masimo Rad-97 reference device. Advantages of the EarlySense device are that it is contactless and
does not require disposable components. However, limitations
include lack of MCPM when the neonate is not in bed, and lack
of oxygen saturation monitoring. Notably, the Masimo Rad-97
capnography cannula was removed when the neonate was not
in bed.
The accuracy of the EarlySense device was confirmed in a
study population of high-risk adult surgical patients and in a
small feasibility series with a paediatric and adult patient population in a sleep laboratory and intensive care unit setting.21 22
Other studies of monitoring technologies have been conducted
in low-resource settings23–26; however, research conducted in
neonates has largely been limited to studies in high-resource
settings. Well-established methods for HR and RR monitoring
exist, but limitations including inaccuracy, invasiveness, time-
consuming application and high cost have prompted development of novel technologies.27–29 Novel contactless technologies
are attractive as they avoid discomfort and risk of skin irritation.
However, they have limitations of their own including motion
artefacts, poor sensor coupling, poor-
quality recordings and
dependency on adequate lighting.28 29 There is a strong need for
additional studies evaluating neonatal monitoring technology in
low-resource settings.
Major strengths of our study were the independence of the
investigators conducting the analysis, robust measurement of
RR with high-
resolution capnography, manual counting of
breaths and randomised selection of minutes for comparison.
However, our study site was better resourced than is typical
in the region, and it is possible that the device may not have
performed as well in a less-resourced environment. Currently,
we are completing our next phase at Pumwani Maternity
Hospital in Nairobi, Kenya, the largest referral maternal
hospital in sub-Saharan Africa and a site more representative of
a low-resource setting.
A substantial percentage (19.1%) of neonate recordings were
not included for analysis due to data synchronisation and data
identification issues (incorrect dates assigned). To minimise
uncertainty in the reference device data and to avoid the EarlySense device missing the a priori threshold due to poor quality
reference device data, we removed a substantial proportion
of reference minutes from analysis and only included minutes
with the highest quality reference data. In addition, we did not
study clinical correlations or outcomes and were unable to assess
the degree to which findings represented clinically significant
differences. In the next phase of our study, we will assess the
clinical feasibility of the EarlySense device with regard to accuracy, up-time, and event detection of high and low HR and RR
events. Many of the neonates in this study were healthy, or relatively healthy, so it is possible that the agreement we observed
may not reflect the sensor performance in critically ill neonates
with higher or more irregular HRs and/or RRs. The EarlySense
investigational device algorithms were developed in a cohort
of neonates who were not critically ill to ensure that the initial
evaluation and optimisation was performed in a more controlled
environment, as is typically done for regulatory approval, before
extending to more challenging cases and environments. We
found the performance of this innovative non-invasive MCPM
device to be promising in neonates. In a qualitative study, we
found that healthcare administrators, healthcare providers
5
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Figure 4 Bland-Altman plots for manual counts of respiratory rate (RR). (A) Open-label round. (B) Closed-label round one. (C) Closed-label round
two. (D) Closed-label round three. Colours indicate which participant neonate is associated with the measurement pair.

and caregivers considered the EarlySense device to be feasible,
useable and acceptable.30
Moving forward, it will be valuable to evaluate the EarlySense
device for agreement with a reference device in neonates in
intensive or critical care. A future study assessing the agreement
of the EarlySense device HR and RR to ECG-derived HR and
RR would strengthen the evidence for adoption of this novel
contactless technology. In addition, evaluating the threshold and
adaptive alerts provided by the device, and establishing cost-
effectiveness, and clinical effectiveness will be necessary before
large-scale implementation can be considered.
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